HMED 3075 Lecture Notes - Lecture 18: Pharmacogenomics, Pharmacogenetics, Personalized Medicine
Document Summary
Hmed 3075 lecture notes on 11/28/16 market race: lecture: pharmacogenomic innovations, reading: Deborah bolnick et al. , the science and business of genetic ancestry. Alondra nelson, bio science: genealogy testing and the pursuit of african ancestry . Pharmacogenetics: the study of how ge(cid:374)es affe(cid:272)t a perso(cid:374)"s respo(cid:374)se to drugs. Pharmacogenomics: screening the genome for pharmacogenetic reactions. Physicians understand that people have different reactions to the treatments they receive. Pharmaceutical companies became intensely interested in pharmacogenomics drug development in the late 1990s. Companies instead develop drugs targeted to these specific genetic variants: removes uncertainty from the drug development process, reduces potential for adverse drug reactions, reduces drug development costs by shortening length of trials and thus time to. Fda approval: will reduce health care expenditures on prescription drugs. Information available on the fda website and from the drug label. Companies like genesight offers pharmacogenetics testing that help determine drugs to prescribe.
